Human Molecular Genetics, 2003, Vol. 12, No. 9 1055-1061
DOI: 10.1093/hmg/ddg120
© 2003 Oxford University Press
Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families
1IST-Genova c/o 2Department of Oncology and Surgical Sciences, Azienda Ospedaliera, Padua, Italy
Received January 13, 2003; Accepted March 6, 2003
The recent identification of major genomic rearrangements in breast and breast/ovarian cancer families has widened the mutational spectrum of the BRCA1 gene, thus increasing the number of informative patients who can benefit from molecular screening. Numerous types of alterations have been identified in different populations with variable frequencies, probably due to both ethnic diversity and the technical approach employed. In fact, although several methods have been successfully used to detect large genomic deletions and insertions, most are laborious, time-consuming, and of variable sensitivity. In order to estimate the contribution of BRCA1 genomic rearrangements to breast/ovarian cancer predisposition in Italian families, we applied, for the first time as a diagnostic tool, the recently described multiplex ligation-dependent probe amplification (MLPA) methodology. Among the 37 hereditary breast/ovarian cancer (HBOC) families selected, all had a high prior probability of BRCA1 mutation, and 15 were previously shown to carry a mutation in either the BRCA2 (five families) or BRCA1 gene (10 families, including one genomic rearrangement). The application of BRCA1-MLPA to the remaining 22 uninformative families allowed the identification of five additional genomic rearrangements. Moreover, we observed that loss of constitutive heterozygosity of polymorphic markers in linkage disequilibrium is predictive of such BRCA1 alterations. By means of this approach, we demonstrate that BRCA1 genomic deletions account for more than one-third (6/15) of the pathogenic BRCA1 mutations in our series. We therefore propose to systematically include MLPA in the BRCA1 mutational analysis of breast/ovarian cancer families.
* To whom correspondence should be addressed at: Department of Oncology and Surgical Sciences, Oncology Section, via Gattamelata 64, I-35128 Padua, Italy. Tel: +39 498215881; Fax: +39 498072854; Email: montagna{at}unipd.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Malacrida, S. Agata, M. Callegaro, C. Casella, D. Barana, M. C. Scaini, S. Manoukian, C. Oliani, P. Radice, M. Barile, et al. BRCA1 p.Val1688del Is a Deleterious Mutation That Recurs in Breast and Ovarian Cancer Families From Northeast Italy J. Clin. Oncol., January 1, 2008; 26(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. John, A. Miron, G. Gong, A. I. Phipps, A. Felberg, F. P. Li, D. W. West, and A. S. Whittemore Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic Groups JAMA, December 26, 2007; 298(24): 2869 - 2876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de la Hoya, S. Gutierrez-Enriquez, E. Velasco, A. Osorio, A. S. de Abajo, A. Vega, R. Salazar, E. Esteban, G. Llort, R. Gonzalez-Sarmiento, et al. Genomic Rearrangements at the BRCA1 Locus in Spanish Families with Breast/Ovarian Cancer Clin. Chem., August 1, 2006; 52(8): 1480 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Walsh, S. Casadei, K. H. Coats, E. Swisher, S. M. Stray, J. Higgins, K. C. Roach, J. Mandell, M. K. Lee, S. Ciernikova, et al. Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer JAMA, March 22, 2006; 295(12): 1379 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nanda, L. P. Schumm, S. Cummings, J. D. Fackenthal, L. Sveen, F. Ademuyiwa, M. Cobleigh, L. Esserman, N. M. Lindor, S. L. Neuhausen, et al. Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women: A Comparative Analysis of BRCA1 and BRCA2 Mutations in American Families of European and African Ancestry JAMA, October 19, 2005; 294(15): 1925 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Agata, M Dalla Palma, M Callegaro, M C Scaini, C Menin, C Ghiotto, O Nicoletto, G Zavagno, L Chieco-Bianchi, E D'Andrea, et al. Large genomic deletions inactivate the BRCA2 gene in breast cancer families J. Med. Genet., October 1, 2005; 42(10): e64 - e64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cruts, R. Rademakers, I. Gijselinck, J. van der Zee, B. Dermaut, T. de Pooter, P. de Rijk, J. Del-Favero, and C. van Broeckhoven Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region Hum. Mol. Genet., July 1, 2005; 14(13): 1753 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A M Woodward, T A Davis, A G S Silva, kConFab Investigators, J A Kirk, and J A Leary Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families J. Med. Genet., May 1, 2005; 42(5): e31 - e31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Ward, B. C. Hendrickson, T. Judkins, A. M. Deffenbaugh, B. Leclair, B. E. Ward, and T. Scholl A Multi-Exonic BRCA1 Deletion Identified in Multiple Families through Single Nucleotide Polymorphism Haplotype Pair Analysis and Gene Amplification with Widely Dispersed Primer Sets J. Mol. Diagn., February 1, 2005; 7(1): 139 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pavlicek, V. N. Noskov, N. Kouprina, J. C. Barrett, J. Jurka, and V. Larionov Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition Hum. Mol. Genet., November 15, 2004; 13(22): 2737 - 2751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Eldering, C. A. Spek, H. L. Aberson, A. Grummels, I. A. Derks, A. F. de Vos, C. J. McElgunn, and J. P. Schouten Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways Nucleic Acids Res., December 1, 2003; 31(23): e153 - e153. [Abstract] [Full Text] [PDF]
|
|